Correlation Between Artiva Biotherapeutics, and Unilever PLC
Can any of the company-specific risk be diversified away by investing in both Artiva Biotherapeutics, and Unilever PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Artiva Biotherapeutics, and Unilever PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Artiva Biotherapeutics, Common and Unilever PLC ADR, you can compare the effects of market volatilities on Artiva Biotherapeutics, and Unilever PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Artiva Biotherapeutics, with a short position of Unilever PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Artiva Biotherapeutics, and Unilever PLC.
Diversification Opportunities for Artiva Biotherapeutics, and Unilever PLC
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Artiva and Unilever is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Artiva Biotherapeutics, Common and Unilever PLC ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unilever PLC ADR and Artiva Biotherapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Artiva Biotherapeutics, Common are associated (or correlated) with Unilever PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unilever PLC ADR has no effect on the direction of Artiva Biotherapeutics, i.e., Artiva Biotherapeutics, and Unilever PLC go up and down completely randomly.
Pair Corralation between Artiva Biotherapeutics, and Unilever PLC
Given the investment horizon of 90 days Artiva Biotherapeutics, is expected to generate 2.39 times less return on investment than Unilever PLC. In addition to that, Artiva Biotherapeutics, is 5.55 times more volatile than Unilever PLC ADR. It trades about 0.0 of its total potential returns per unit of risk. Unilever PLC ADR is currently generating about 0.05 per unit of volatility. If you would invest 5,523 in Unilever PLC ADR on September 19, 2024 and sell it today you would earn a total of 335.50 from holding Unilever PLC ADR or generate 6.07% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 84.13% |
| Values | Daily Returns |
Artiva Biotherapeutics, Common vs. Unilever PLC ADR
Performance |
| Timeline |
| Artiva Biotherapeutics, |
| Unilever PLC ADR |
Artiva Biotherapeutics, and Unilever PLC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Artiva Biotherapeutics, and Unilever PLC
The main advantage of trading using opposite Artiva Biotherapeutics, and Unilever PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Artiva Biotherapeutics, position performs unexpectedly, Unilever PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unilever PLC will offset losses from the drop in Unilever PLC's long position.| Artiva Biotherapeutics, vs. Unilever PLC ADR | Artiva Biotherapeutics, vs. Acme United | Artiva Biotherapeutics, vs. Anterix | Artiva Biotherapeutics, vs. European Wax Center |
| Unilever PLC vs. Helen of Troy | Unilever PLC vs. European Wax Center | Unilever PLC vs. Spectrum Brands Holdings |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |